Rapid Onset of Nucleolar Segregation Followed by DNA Fragmentation in Roscovitine-Treated MCF-7 Cells Supports Its Pro-Apoptotic Potential

le Kotala, V., Horky, M., Uldrijan, S., Strnad, M., Vojtesek, B.
Foilsithe in ScientificWorldJournal (2001)

Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition

le Pastorek, M., Muller, P., Coates, P. J., Vojtesek, B.
Foilsithe in PLoS One (2018)

Biochemical analysis of the stress protein response in human oesophageal epithelium

le Hopwood, D, Moitra, S, Vojtesek, B, Johnston, D, Dillon, J, Hupp, T
Foilsithe 1997

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.

le Vojtĕsek, B., Fisher, C. J., Barnes, D. M., Lane, D. P.
Foilsithe 1993

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.

le Bártek, J., Petrek, M., Vojtĕsek, B., Bártková, J., Kovarík, J., Rejthar, A.
Foilsithe 1987

Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer

le Kolář, Z, Murray, P G, Scott, K, Harrison, A, Vojtěšek, B, Dušek, J
Foilsithe 2000

Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers...

le Craig, A L, Burch, L, Vojtesek, B, Mikutowska, J, Thompson, A, Hupp, T R
Foilsithe 1999

TAp63gamma is required for the late stages of myogenesis

le Cefalù, S, Lena, AM, Vojtesek, B, Musarò, A, Rossi, A, Melino, G, Candi, E
Foilsithe in Cell Cycle (2015)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

le Fisher, C. J., Gillett, C. E., Vojtĕsek, B., Barnes, D. M., Millis, R. R.
Foilsithe 1994

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

le Lichnovský, V, Kolár, Z, Murray, P, Hlobilková, A, Cernochová, D, Pospísilová, E, Vojtĕsek, B, Nenutil, R
Foilsithe 1998

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

le Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
Foilsithe 1995

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

le Mad’arová, J, Lukešová, M, Hlobilková, A, Strnad, M, Vojtěšek, B, Lenobel, R, Hajdúch, M, Murray, P G, Perera, S, Kolář, Z
Foilsithe 2002

p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

le Turnquist, C, Horikawa, I, Foran, E, Major, E O, Vojtesek, B, Lane, D P, Lu, X, Harris, B T, Harris, C C
Foilsithe in Cell Death Differ (2016)

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.

le Speiser, P., Gharehbaghi-Schnell, E., Eder, S., Haid, A., Kovarík, J., Nenutil, R., Sauter, G., Schneeberger, C. H., Vojtesek, B., Wiltschke, C. H., Zeillinger, R.
Foilsithe 1996

Identification and role of migration stimulating factor isoforms in breast carcinomas

le Schor, AM, Ellis, IR, Jones, SJ, Perrier, S, Florence, MM, Cox, J, Ohe, G, Kankova, K, Vojtesek, B, Thompson, AM, Purdie, C, Kazmi, S, Foo, S, Woolston, AM, Schor, SL
Foilsithe 2008